DEFB1 gene 59 untranslated region (UTR) polymorphisms in inflammatory bowel diseases

Clinics

Volumn 67, Issue 4, 2012, Pages 395-398

  Zanin, Valentina ^a   Segat, Ludovica ^b   Bianco, Anna Monica ^b   Padovan, Lara ^b   de Alencar Cunha Tavares, Nathalia ^c   Crovella, Sergio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; DEFB1 PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CASE CONTROL STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; MALE; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

5' UNTRANSLATED REGIONS; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860135980     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(04)14     Document Type: Article

References (27)

1. Papp M, Norman GL, Altorjai I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol. 2007;13(14):2028-36.
2. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122(1):44-54, http://dx.doi.org/10.1053/ gast.2002.30294.
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115(1):182-205, http://dx.doi.org/10.1016/ S0016-5085(98)70381-6.
4. Balfour Sartor R. Bacteria in Crohn's disease: mechanisms of inflamma-tion and therapeutic implications. J Clin Gastroenterol. 2007;41 Suppl:S37-43, http://dx.doi.org/10.1097/MCG.0b013e31802db364
5. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res. 2000;1:141-50, http://dx.doi.org/10.1186/rr25.
6. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat RevImmunol. 2006;6(6):447-56, http://dx.doi.org/10.1038/nri1860.
7. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, et al.Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutro-phils. J Biol Chem. 1996;271(6):2935-40.
8. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286(5439):525-8, http://dx.doi.org/10.1126/ science.286.5439.525.
9. Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology. 2004;111(3):273-81, http://dx.doi.org/ 10.1111/j.0019-2805.2004.01816.x.
10. Arijs I, De Hertogh G, Lemaire K, Quintens R, Van Lommel L, Van Steen K, et al. Mucosal Gene Expression of antimicrobial peptides in inflamamatory bowel disease before and after first Infliximab treatment. PloS One. 2009;4(11):e7984, http://dx.doi.org/10.1371/journal.pone. 0007984.
11. Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, et al Modulation of host antimicrobial peptide (b-defensins 1and2) expression during gastritis. Gut. 2002;51(3):356-61, http://dx.doi.org/ 10.1136/gut.51.3.356.
12. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, et al. Inducible and costitutive-defensis are differentially expressed in Crohn's disease and ulcerative colitis. Inflammatory Bowel Disease. 2003;9(4):215-23.
13. Ramasundara M, Leach ST, Lemberg DA, Day AS. Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol. 2009;24(2):202-8, http://dx.doi.org/10.1111/j. 1440-1746.2008.05772.x.
14. Fellermann K, Wehkamp J, Herrlinger K.R, Stange E.F. Crohn's disease: a defensin deficiency syndrome? Eur J Gastroenterol Hepatol. 2003;15(6):27-634, http://dx.doi.org/10.1097/01.meg.0000059151.68845.88.
15. Milanese M, Segat L, Crovella S. Transcriptional effect of DEFB1 gene 59 untranslated region polymorphisms. Cancer Res. 2007;67(12):5997, http://dx.doi.org/10.1158/0008-5472.CAN-06-3544.
16. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, et al. Human b-defensin 1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 2006;66(17):8542-9, http://dx.doi.org/10.1158/ 0008-5472.CAN-06-0294.
17. Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis. 2008;2(1):1-23, http://dx.doi.org/10.1016/j.crohns. 2007.11.001.
18. Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis. 2008;2(1):1-23, http://dx.doi.org/10.1016/j.crohns. 2007.11.001.
19. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol. 2009;104(1):235-41; quiz 234, 242, http://dx.doi.org/10.1038/ajg.2008.16.
20. Braida L, Boniotto M, Pontillo A, Tovo PA, Amoroso A, Crovella S. A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with hiv-1 infection in italian children. AIDS. 2004; 18(11):1598-600, http://dx.doi.org/10.1097/01.aids.0000131363.82951. fb.
21. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (snps) in human beta-defensin 1: High-throughput snp assays and association with candida carriage in type i diabetics and nondiabetic controls. J Clin Microbiol. 2003;41(1):90-6, http://dx. doi.org/10.1128/JCM.41.1.90-96.2003.
22. Excoffier L, Laval G, Schneider S. Arlequin ver 3.0: an integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online. 2005;1:47-50.
23. Kocsis AK, Lakatos PL, Somogyvári F, Fuszek P, Papp J, Fischer S, et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scandinavian Journal of Gastroenterology. 2008; 43(3):299-307, http://dx.doi.org/10.1080/00365520701682615.
24. Prado-Montes de Oca E, García-Vargas A, Lozano-Inocencio R, Gallegos-Arreola MP, Sandoval-Ramírez L, Dávalos-Rodríguez NO, et al. Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol. 2007;142(3):211-18, http:// dx.doi.org/10.1159/000097023.
25. Chakraborty K, Ghosh S, Koley H, Mukhopadhyay AK, Ramamurthy T, Saha DR, et al. Bacterial exotoxins downregulate cathelicidin (hCAP18/ LL37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol. 2008;10(10):2520-37, http://dx.doi.org/ 10.1111/j.1462-5822.2008.01227.x.
26. Sherman H, Chapnik N, Froy O. Albumin and amino acids upregulate the expression of human beta-defensin 1. Mol Immunol. 2006;43(10):1617-23, http://dx.doi.org/10.1016/j.molimm.2005.09.013.
27. Sherman H, Froy O. Expression of human beta-defensin 1 is regulated via c-Myc and the biological clock. Mol Immunol. 2008;45(11):3163-67, http://dx.doi.org/10.1016/j.molimm.2008.03.004.